HUMAN MESANGIAL CELLS ARE RESISTANT TO PRODUCTIVE INFECTION BY MULTIPLE STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2

被引:44
|
作者
ALPERS, CE
MCCLURE, J
BURSTEN, SL
机构
[1] UNIV WASHINGTON, SCH MED, DEPT MED, SEATTLE, WA 98195 USA
[2] VET ADM MED CTR, SEATTLE, WA 98108 USA
[3] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, SEATTLE, WA USA
关键词
HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY; MESANGIAL CELLS;
D O I
10.1016/S0272-6386(12)70120-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Human immunodeficiency virus-associated nephropathy (HIVAN) is a recognized clinical entity of unknown pathogenesis. A role for viral infection of renal cells in the initiation of this process at present is an intriguing but untested hypothesis. Studies in primate models of acquired immunodeficiency syndrome (AIDS) suggest that injury to the mesangial cell may be central to the sclerosing glomerular lesion characteristic of HIVAN. We therefore tested the infectibility of human mesangial cells (HMC) in vitro by a variety of strains of HIV chosen to include a spectrum of tropisms for different cell types. Productive infection of mesangial cells could not be demonstrated using any of the virus strains. Nonetheless, HIV infection of intrinsic renal cells remains an attractive area of inquiry for understanding the natural history of HIVAN. © 1992, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 50 条
  • [21] HUMAN-IMMUNODEFICIENCY-VIRUS, TYPE-2
    BEKTIMIROV, TA
    VOPROSY VIRUSOLOGII, 1990, 35 (03) : 180 - 183
  • [22] CROSS-NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS ISOLATES
    ROBERTGUROFF, M
    ALDRICH, K
    MULDOON, R
    STERN, TL
    BANSAL, GP
    MATTHEWS, TJ
    MARKHAM, PD
    GALLO, RC
    FRANCHINI, G
    JOURNAL OF VIROLOGY, 1992, 66 (06) : 3602 - 3608
  • [23] SPECIFIC-INHIBITION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND THE CHIMERIC ENZYMES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 BY NONNUCLEOSIDE INHIBITORS
    HIZI, A
    TAL, R
    SHAHARABANY, M
    CURRENS, MJ
    BOYD, MR
    HUGHES, SH
    MCMAHON, JB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1037 - 1042
  • [24] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    WEI, XP
    GHOSH, SK
    TAYLOR, ME
    JOHNSON, VA
    EMINI, EA
    DEUTSCH, P
    LIFSON, JD
    BONHOEFFER, S
    NOWAK, MA
    HAHN, BH
    SAAG, MS
    SHAW, GM
    NATURE, 1995, 373 (6510) : 117 - 122
  • [25] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    SHAW, GM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S83 - S83
  • [26] QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION KINETICS
    DIMITROV, DS
    WILLEY, RL
    SATO, H
    CHANG, LJ
    BLUMENTHAL, R
    MARTIN, MA
    JOURNAL OF VIROLOGY, 1993, 67 (04) : 2182 - 2190
  • [27] MALIGNANCIES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    ARICO, M
    CASELLI, D
    DARGENIO, P
    DELMISTRO, AR
    DEMARTINO, M
    LIVADIOTTI, S
    SANTORO, N
    TERRAGNA, A
    CANCER, 1991, 68 (11) : 2473 - 2477
  • [28] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF NEURAL XENOGRAFTS
    CVETKOVICH, TA
    LAZAR, E
    BLUMBERG, BM
    SAITO, Y
    ESKIN, TA
    REICHMAN, R
    BARAM, DA
    DELCERRO, C
    GENDELMAN, HE
    DELCERRO, M
    EPSTEIN, LG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5162 - 5166
  • [29] PATHOGENESIS OF PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    WILFERT, CM
    WILSON, C
    LUZURIAGA, K
    EPSTEIN, L
    JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02): : 286 - 292
  • [30] PSYCHONEUROIMMUNOLOGY AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION REVISITED
    GOODKIN, K
    MULDER, CL
    BLANEY, NT
    IRONSON, G
    KUMAR, M
    FLETCHER, MA
    ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) : 246 - 247